Bayer and MOMA Therapeutics enter collaboration and license agreement in Oncology
Companies will collaborate to develop a high-value small molecule program, further enhancing Bayer’s precision oncology development portfolio / MOMA will receive an upfront payment and collaboration fee and is eligible to receive near-term discovery,…